Abingworth LLP Exicure, Inc. Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
A detailed history of Abingworth LLP transactions in Exicure, Inc. stock. As of the latest transaction made, Abingworth LLP holds 281,636 shares of XCUR stock, worth $833,642. This represents 0.11% of its overall portfolio holdings.
Number of Shares
281,636
Previous 281,636
-0.0%
Holding current value
$833,642
Previous $439,000
26.42%
% of portfolio
0.11%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding XCUR
# of Institutions
16Shares Held
766KCall Options Held
0Put Options Held
0-
Carlyle Group Inc. Washington, DC282KShares$833,6420.01% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$167,2960.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA46KShares$136,1650.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$118,6750.0% of portfolio
-
Ubs Group Ag17.3KShares$51,2400.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $14.7M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...